Replimune Group Inc.

NASDAQ: REPL
Share price (8/15/25): $5.56
Market cap (8/15/25): $434 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q1

ended 03/31/25 FY 2025

ended 12/31/24 Q3

ended 09/30/24 Q2

ended 06/30/24 Q1

Prospectuses and Registrations Filter

Shelf registration

Shelf registration

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Point72 Asset Management, L.P.

Astley-Sparke Philip

Xynos Konstantinos

Schwendenman Andrew

News Filter

Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update

Receives Complete Response Letter From FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

Material Disclosure

Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Material Definitive Agreement, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness